Through adult stem cell treatment patients with Multiple Sclerosis are getting their lives back. When it comes to making a difference in people’s lives, adult stem cells are ethically far superior in practice to stem cells taken from embryonic human beings. And by using the patient’s own cells, you’ve precluded transplant rejection. Moreover, unlike embryonic stem cells, adult stem cells carry no concern of tumors.

Great that treatment utilizing adult stem cells for patients suffering from degenerating diseases is happening, furthermore it is wonderful to see positive media coverage. The only problem is the reference to the success of this treatment as 'miraculous'. The benefits of stem cell therapy are not miraculous as they are happening everyday all over the world. - RCSI

Am I a candidate for stem cell treatment for Multiple Sclerosis?

Pioneering use of adult stem cells is making huge improvement in the condition of MS patients

By Dave Andrusko

Recovery: MS sufferer Holly Drewery became wheelchair-bound after the birth of daughter Isla, but thanks to the stem cell transplant she can dance, run and chase after Isla in the park

If we’ve written once about the successful uses of adult stem cells, we’ve probably written 50 times, demonstrating that ethically unobjectionable adult stem cells are far superior in practice to stem cells taken from embryonic human beings.

When it comes to making a difference in people’s lives, adult stem cells– isolated from many different tissues, including bone marrow, blood, muscle, fat, and umbilical cord blood–are the gold standard.

The latest evidence comes courtesy of a story in the Daily Mail. In typical Daily Mail fashion the headline is anything but understated: “Dancing, walking and running again, the wheelchair-bound MS patients after they were given ‘miraculous’ stem cell treatment.”

But while the headline over Fiona Macrae’s story seems a bit overstated, her story quietly demonstrates that real progress is being made in treating multiple sclerosis, a devastating disease. I asked David Prentice, an expert on stem cells of all kinds, what he thought of the study, lead by Professor Basil Sharrack, of the Royal Hallamshire Hospital in Sheffield. He told NRL News Today

This is another gratifying example of the successful application of adult stem cells. Prof. Sharrack and colleagues are to be congratulated for undertaking this study, which has shown extremely promising results. Their publication of the data in the Journal of the American Medical Association adds even more evidence to the already-substantial successes for adult stem cell treatments for patients. The protocol they use, pioneered by Dr. Richard Burt at Northwestern University (who is also a co-author on the JAMA paper), involves harvest and purification of some of the patient’s bone marrow adult stem cells, then chemotherapy to kill the rogue immune cells that are causing the autoimmune problem of multiple sclerosis, followed by re-infusion of the patient’s adult stem cells. The patient’s adult stem cells “reboot” their immune and blood system, and also seem to facilitate some repair of the nervous system.

There are also two hurtles that are bypassed. By using the patient’s own cells, you’ve precluded transplant rejection. Moreover, unlike embryonic stem cells, adult stem cells carry no concern of tumors.

Macrae’s story provides two encouraging examples.

Holly Drewery was plagued with numbness and blurred vision. She was diagnosed with MS. Her health grew worse, as Macrae writes.

She became wheelchair-bound after her health worsened on Isla’s [her daughter’s] birth. She needed help with basic tasks and couldn't’t even wiggle her toes.

Three weeks after the stem cell transplant she was able to walk out of hospital.

Now, more than 18 months on, she is almost back to normal. She has a part-time office job and, although she still gets tired, can dance, run and chase after Isla, two, in the park.

She said: ‘All I wanted to be able to do is take Isla out. It worked wonders. I am more or less back to normal.’

Another patient, Sam Ramsey, was paralyzed from the neck down by MS after she collapsed when out celebrating her 22nd birthday.

Nothing worked until the adult stem cell treatment. Now she can walk on crutches and can drive.

“This treatment has given me my life back,” she told the Sunday Times. “This is not a word I would use lightly but we have seen profound neurological improvements.”

Of course more follow-up must be done to ensure that the amazing progress is not short-lived. But toward the very end of the story comes this very encouraging secondary improvement:

As well as stopping the disease in its tracks the treatment, known as autologous haematopoietic stem cell transplantation, seems to heal damage that has already been done.^via

Am I a candidate for stem cell treatment for Multiple Sclerosis?

At a Health Affairs panel Tuesday researchers spoke about the costs of false-positive mammograms and breast cancer over diagnoses in the U.S. Researchers believe by applying the false-positive rate of 11%, nearly 3.2 million women would receive false positive mammograms each year, at a cost of $2.8 billion annually. For years, a DCIS finding automatically led to bilateral mastectomy. However, providers now realize that it often does not progress and sometimes is actually not even cancerous.These false-positive screenings expose patients to additional diagnostic workup and psychological distress.

MAMMOGRAPHY'S $4-BILLION PROBLEM

Millions of women receive false-positive results annually, and 20,000 are over treated.

by Shannon Firth
Contributing Writer

WASHINGTON -- For too many women, breast cancer screening does more harm than good, a researcher said here.

Kenneth Mandl, PhD, a professor at Harvard Medical School and director of the Boston Children's Hospital Informatics Program, and Mei-Sing Long, PhD, a research fellow at the hospital, examined the costs of false-positive mammograms and breast cancer overdiagnoses in the U.S. Mandl spoke at a Health Affairs panel about the cost and quality of cancer care Tuesday.

"There's a $4-billion problem, and it's $4 billion dollars being spent on two undesirable outcomes," he said, referring to false-positive results and overtreatment of breast cancer.

The magnitude of the financial problem will likely grab policymakers' attention first, but what's important is the human cost, he said.

"There are many women who are brave enough to face a false-positive thinking they that they are ultimately protecting themselves from cancer, and it's a small price to pay. The calculus changes if the protection from cancer is very small," Mandl told MedPage Today.

Providers, patients, and their families need to have a clear understanding of the facts around mammography screening, including "the magnitude of the benefit and the likelihood of the harm," he said.

Mandl and Ong obtained cost data from a major healthcare insurance carrier covering some 700,000 women 40 to 59 years old, who had undergone routine mammograms from 2011 to 2013. The data included demographic characteristics as well as all their medical claims.

The researchers excluded women receiving mammography for diagnostic reasons, those who had been screened within 9 months prior to the index screen, and women with a high risk of breast cancer, "since they may have been undergoing surveillance mammography instead of routine screening," the report noted.

Mandl and Ong defined a false-positive mammogram as a screening test that is later revealed not to be cancer, yet "exposes patients to additional diagnostic workup and psychological distress."

They define overdiagnosis as identifying lesions that are "unlikely to become clinically evident during the lifetime of a patient [that ] exposes patients to the harm of overtreatment." Amounts the insurance company paid to healthcare providers for patients' services, excluding copayments, coinsurance, and deductibles, were totaled to reflect costs of diagnosis and treatment.

False-positive findings were returned in 11% of the routine screening mammograms included in the analysis.

In the U.S., with 21.2 million women ages 40 to 49 and another 22.4 million 50 to 59, and with screening rates of about 62% and 73%, respectively, the researchers estimated that about 29.5 million women in these age groups received mammograms in a year. Using the false-positive rate of 11%, they calculated that nearly 3.2 million women would receive false positive mammograms each year, at a cost of $2.8 billion annually.

The researchers also calculated that in the 40-to-59 age group there would be 114,298 screen-detected cancers, of which about one-fifth would be ductal carcinoma in situ (DCIS) and the rest invasive tumors. Citing an overdiagnosis rate of 22%, based on recent studies, the researchers calculated that 20,116 women would be overdiagnosed with invasive breast cancer, at a cost of $1 billion each year. (Mandl and Ong were unable to determine which breast cancers were overdiagnosed using the claims data. "Thus we applied published overdiagnosis rates to determine the number of women who were likely to have been overdiagnosed," they noted in their report.)

"Here, we're talking about someone who's asymptomatic, not concerned about why they're sick, and not looking for a diagnosis," said Mandl.

The rate of overdiagnosis for ductal carcinoma in situ (DCIS) is a shocking 86%, according to the largest most recent study. For years, a DCIS finding automatically led to bilateral mastectomy, Mandl said. However, providers now realize that it often does not progress and sometimes is actually not even cancerous.

Mandl and Ong estimated the cost of DCIS overdiagnosis nationwide to be $243 million.

In total, they estimated costs of $1.2 billion in overdiagnoses for both invasive breast cancer and DCIS and another $2.8 billion for the workup and treatment costs associated with false positives.

Since 2009, the U.S. Preventive Services Task Force has recommended breast cancer screening every other year, for women ages 50 to 74. For women under 50 years old, the Task Force notes, "The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take patient context into account, including the patient's values regarding specific benefits and harms."

Ong and Mandl in their report's conclusion suggested that selective screening could benefit more patients than routine screening by age alone.

In selective screening, factors such as age, family history, genetic predisposition, breast density changes, and characteristics of mammography should help decide which women should receive screening, Mandl explained.

The idea is to limit screening to women for whom it clearly has a positive benefit-harm balance, although no specific algorithm for selective screening has been widely accepted.

In their Health Affairs paper, the researchers also noted that more research is needed "to develop risk-based stratification models" to prevent overtreatment of correctly diagnosed cancers and DCIS.

As for the impact of their report, Mandl said he hopes it will contribute to an understanding of the economics and explain why the "status quo" of current practices is so firmly entrenched.

"Any change in recommendation will shift the revenue one way or another and that has to be an explicit part of the conversation," Mandl said.via

Are you a Candidate for Breast Cancer Treatment?

One of the first places in the brain to degenerate in people with Alzheimer's disease is the front part of the temporal lobe that evolved from the smell system, this portion of the brain is involved in forming new memories. A grad student at the University of Florida has came up with the idea of using peanut butter to test for smell sensitivity. At UF, the peanut butter test will be one more tool to add to a full suite of clinical tests for neurological function in patients with memory disorders.

Peanut butter helps diagnose Alzheimer's disease

Peanut butter on teaspoon

Researchers found that by placing a dollop of peanut butter on a ruler,
they could identify early stages of Alzheimer's disease,
based on patients' ability to detect the odor at certain distances.

A dollop of peanut butter and a ruler can be used to confirm a diagnosis of early stage Alzheimer's disease, University of Florida Health researchers have found.

Jennifer Stamps, a graduate student in the University of Florida (UF) McKnight Brain Institute Center for Smell and Taste, and her colleagues reported the findings of a small pilot study in the Journal of the Neurological Sciences.

Stamps came up with the idea of using peanut butter to test for smell sensitivity while she was working with Dr. Kenneth Heilman, one of the world's best known behavioral neurologists, from the UF College of Medicine's department of neurology.

While shadowing doctors in Heilman's clinic, she noticed that patients were not tested for their sense of smell. The ability to smell is associated with the first cranial nerve and is often one of the first things to be affected in cognitive decline.

"Dr. Heilman said, 'If you can come up with something quick and inexpensive, we can do it,'" Stamps says.

She thought of peanut butter because, she said, it is a "pure odorant" that is only detected by the olfactory nerve and is easy to access.

Widespread problem

According to the Alzheimer's Association, Alzheimer's disease affects 5.2 million people in the US and will cost the nation $203 billion in this year alone.

The Association estimates that one American develops Alzheimer's every 68 seconds, and they expect to see this figure rise to one American every 33 seconds by 2050.

In the study, patients who were coming to the clinic for testing also sat down with a clinician, who was armed with 14 grams of peanut butter - which equals about 1 tablespoon - and a metric ruler. The patient closed his or her eyes and mouth and blocked one nostril.

The clinician opened the peanut butter container and held the ruler next to the open nostril while the patient breathed normally. By moving the peanut butter up the ruler 1 cm at a time during the patient's exhalation, they were able to measure the distance at which the patient could detect the odor.

The distance was recorded and the procedure repeated on the other nostril after a 90-second delay.

The clinicians running the test did not know the patients' diagnoses, which were not usually confirmed until weeks after the initial clinical testing.

Sense of smell loss

The scientists found that patients in the early stages of Alzheimer's disease had a dramatic difference in detecting odor between the left and right nostril - the left nostril was impaired and did not detect the smell until it was an average of 10 cm closer to the nose than the right nostril had made the detection in patients with Alzheimer's disease.

This was not the case in patients with other kinds of dementia; instead, these patients had either no differences in odor detection between nostrils or the right nostril was worse at detecting odor than the left one.

Of the 24 patients tested who had mild cognitive impairment, which sometimes signals Alzheimer's disease and sometimes turns out to be something else, about 10 patients showed a left nostril impairment and 14 patients did not.

The researchers said more studies must be conducted to fully understand the implications.

Stamps explains:

"At the moment, we can use this test to confirm diagnosis. But we plan to study patients with mild cognitive impairment to see if this test might be used to predict which patients are going to get Alzheimer's disease."

Stamps and Dr. Heilman point out that this test could be used by clinics that do not have access to the personnel or equipment to run other, more elaborate tests required for a specific diagnosis, which can lead to targeted treatment.

At UF Health, the peanut butter test will be one more tool to add to a full suite of clinical tests for neurological function in patients with memory disorders.

Non-invasive, early stage test

One of the first places in the brain to degenerate in people with Alzheimer's disease is the front part of the temporal lobe that evolved from the smell system, and this portion of the brain is involved in forming new memories.

"We see people with all kinds of memory disorders," Heilman said. Many tests to confirm a diagnosis of Alzheimer's disease or other dementias can be time-consuming, costly or invasive. "This can become an important part of the evaluation process."

The UF study could help by detecting a person's likelihood of developing the disease at a much earlier stage, with a non-invasive test.

The Alzheimer's Association acknowledge that at the moment, there is no cure for the disease, nor can current Alzheimer's treatments stop Alzheimer's from progressing. They can, however, temporarily slow the worsening of dementia symptoms. This improves the quality of life for both sufferers and their caregivers.

As Stamps says:

"If we can catch it at that early stage, we can start treatment more aggressively at the early stage and you can possibly prevent a lot of the progression."

Medical News Today reported in July this year that taking certain lifestyle measures, including taking regular exercise and eating a balanced diet, could reduce your risk of developing Alzheimer's.^via

Written by Belinda Weber

To receive a treatment consultation click here

MAN OUT OF WHEELCHAIR AFTER STEM CELL THERAPY

A man with a spinal cord injury suffered 10 years ago has improved his quality of life tremendously after receiving adult stem cells in a new stem cell treatment. Paralyzed in a roofing accident, Jason Slawson was in a wheelchair for 10 years before he went for stem cell therapy and now is using a walker.

LIFTED OUT OF DEPRESSION AS WELL AS HIS WHEELCHAIR

The stem cell treatment has given Jason confidence as well as lifting him out of depression he was feeling (not to mention lifting him out of his wheelchair). From sleeping all day to forget about his depression to working 7 days a week after the stem cell therapy.

BACK TO WORK AFTER ADULT STEM CELL TREATMENT

From the stem cell article: Progress was immediately apparent, muscles he had not used in a decade were contracting and spasms that were violent enough to shake the walls in his home subsided. He admits the road to recovery is still rocky at times. “I am still using the walker and some days I’m not strong enough to make it in public, but I use it every day when I am at home,” Slawson said. “There are days when my legs instantly buckle.”

ARE ADULT STEM CELLS A FOUNTAIN OF YOUTH?

Slawson said he believes that in taking the steps to get back on his feet, he may have discovered the fountain of youth. As his muscles are slowly regenerating and feeling is returning to his lower extremities, Slawson said the stem cell therapy also cured carpel tunnel syndrome. “Before I went for treatment I needed surgery to repair my wrists, I was in a lot of pain from 10 years of gripping and pulling myself in my wheelchair,” Slawson said, with a grin. “Today, I stopped to look at myself in the mirror - and I think I am looking younger.”

MOTHER KNOWS BEST

Jason's mother also sees the difference - Schirman said the $40,000 the family pulled together to send Slawson and his wife to the treatment center was the best investment they could have made for their son’s future. She said he is a changed man who is now staring life in the face instead of hanging his head in defeat.

While she said the physical improvements are more than she ever imagined, she knows the emotional and mental healing far outweighs those benefits. “More important than the physical progress is his renewed sense of self-confidence and hope,” Schirman said. “He is willing to take risks again, gets out every day and is even talking about raising a family of his own.”

ADULT STEM CELLS- NOT AVAILABLE IN THE USA

Stimulating stem-cell growth naturally

The excitement over the tremendous healing and anti-aging power of stem cells continues to build up toward a frenzied acceptance of this new wonder treatment. But stem cells are not new; they are as old as time itself. They have been and always will be inside us.

The approach, however, in harvesting, cultivating and reinfusing stem cells into one’s own system is expensive and not within the reach of the average person. The public is also confused with an avalanche of information on which stem-cell clinic to consult, what stem-cell approach is best, what kind of stem cells to use—whether from a sheep or one’s own adult stem cell.

Despite the Department of Health’s guidelines regarding the superior safety of using adult stem cells over animal sources, the debates continue.

If one were to choose adult stem cells, should it be autologous (coming from your own), or are Russian bone marrow stem cells better than the Japanese women’s placenta stem cells? Better yet, why not have your very own bone marrow stem cells taken from the back of your hip?

Nobody questions the benefits of stem-cell therapy for the brain, heart, lungs, kidney, pancreas, liver, spinal cord, wound-healing—the list is almost endless.

The role of bone marrow stem cells in the healing of the body due to degenerative diseases from accidents and surgeries has been recognized. And its dramatic effect in changing the course of one’s life has been hailed by medical experts as something close to a miracle...

There is another way to derive benefits from your own stem cells. Its source and supply is inside you. Stem cells are found in your brain, blood, bone marrow, fat and skin tissues.

For example, any trauma to the skin and bones naturally triggers the release of bone marrow stem cells. The immediate response is the quick migration of bone marrow stem cells to the injured site.

In the case of burn victims, it was noted that a rapid increase (up to nine times) of bone marrow stem cells was observed in the blood.

What, then, can one do in order to encourage the body to increase stem-cell proliferation?

What can you do in order to affect your own stem cells in a positive way?

It is imperative to understand that there are negative lifestyle habits that greatly suppress the body’s ability to produce and release stem cells. These include cigarette smoking, stress, lack of sleep, emotional extremes, lazy lifestyle and poor nutrition.

So: Don’t smoke; manage your stress positively; get seven to nine hours of good sleep nightly; be in a happy state; exercise daily for 30-45 minutes; do vigorous exercise once a week; eat/drink healthy; and supplement with vitamins plus extra doses of zinc and selenium.

via http://lifestyle.inquirer.net/95093/stimulating-stem-cell-growth-naturally

Stem Cell Therapy Proven to Increase Memory

We’ve all come to accept the notion that our brain will continue to shrink as we age. Nowhere is this decline more impactful than in the hippocampus, the brain’s memory center, one of the primary brain areas that’s first to decline in Alzheimer’s disease.

Researchers measuring the size of the hippocampus using MRI scans demonstrate a clear correlation between shrinkage of the hippocampus and declining cognitive function. So, at least as it relates to the hippocampus, size does matter.

Challenging the status quo notion that loss of hippocampal function is inevitable is new and exciting research showing that we have the potential to actually grow new cells in this vitally important are of the brain, expanding the hippocampus in size and enhancing memory function.

The growth of new cells in the brain, neurogenesis, is enhanced under the influence of a specific protein called BDNF. And while there is no pharmaceutical approach to increasing BDNF, animal research has long recognized that aerobic exercise causes a robust increase in BDNF levels and as a consequence increases both the growth of new cells in the hippocampus as well as increase in memory.

But while the animal research has long confirmed the relationship between aerobic exercise and the growth of new brain cells, this relationship has been only recently demonstrated to occur in humans.

Neuroscientist Kirk Erikson and his research team at the University of Pittsburgh publishing in the Proceedings of the National Academy of Science studied a group of 120 adults over a one year span. Half the group was given a stretching program to perform 3 times each week while the other half did engaged in 3 days of aerobics.

After one year, the 2 groups were evaluated looking at 3 parameters. First, using MRI scans, the change in size of the hippocampus was calculated. Second, serum measurements before and after the trial were measured. And finally, the study actually measured memory function at the beginning and end of the trial.

The results were breathtaking. While the group doing the stretching program manifested a decline in memory, hippocampal size and BDNF levels, the aerobics group showed not only improvement in memory, but an actually increase in the size of the hippocampus accompanied by an increase in their blood levels of BDNF. The authors concluded: “These results clearly indicate that aerobic exercise is neuroprotective and that starting an exercise regimen later in life is not futile for either enhancing cognition or augmenting brain volume.” Simply stated, this landmark research demonstrated that aerobic exercises increases the growth of new stem cells in the human brain, and these stem cells mature to become fully functioning neurons.

What’s more, research just published several weeks ago in the Journal of the American Medical Association showed that blood levels of BDNF almost perfectly predict future risk for developing dementia as long as 10 years in the future.

The results of these studies have huge implications. There is no effective treatment for Alzheimer’s disease and yet, simple aerobic exercise can turn on the genetic machinery to manufacture BDNF, the brain’s “growth hormone,” creating new stem cells that become fully functioning neurons in the brain’s memory center and actually improving memory. Despite the lack of any pharmaceutical development to enhance this process, you have direct control of your BDNF levels and thus the fate of your brain.

You can increase your BDNF levels and enhance the growth of new brain cells and memory. Here’s how:

Engage in regular aerobic exercise. I recommend 20 minutes per day, 6 days each week. A good target heart rate is around 180 minus your age. Your specific target rate will depend on your level of fitness as well as medications you may be taking.
The omega-3 DHA, like aerobic exercise, has been shown to activate the genes that turn on BDNF production. So take a supplement that contains DHA. DHA is available in fish oils as well as algae-derived (suitable for vegetarians). While krill oil is popular, the DHA content is typically only 10% of fish or algae-based products.

Europe recommends approval for first stem-cell therapy

LONDON Fri Dec 19, 2014 8:08am EST

(Reuters) - European regulators have recommended approval of the first medicine containing stem cells to treat a rare condition caused by burns to the eye.

The European Medicines Agency said on Friday that Holoclar, from privately held Italian company Chiesi, had been given a green light for moderate to severe limbal stem cell deficiency due to physical or chemical burns. Left untreated, the condition can result in blindness.

Holoclar is a living tissue product made from a biopsy taken from a small undamaged area of the patient’s cornea and grown in the laboratory using cell culture.

The recommendation by the European agency will now be sent to the European Commission for the adoption of a decision on an EU-wide marketing authorization.

(Reporting by Ben Hirschler; editing by Jason Neely)

EU's top court opens door to some stem cell patents

By Robert-Jan Bartunek and Ben Hirschler - BRUSSELS/LONDON Thu Dec 18, 2014 8:23am EST

A piece of a three-dimensional bone structure obtained from the own adipose stem cells of a patient is seen at Brussels' Saint Luc Hospital January 14, 2014.

Credit: Reuters/Yves Herman

(Reuters) - Europe's top court has opened the door to certain stem cell patents in the European Union by ruling that an organism incapable of developing into a human being is not a human embryo and may be patented.

Thursday's judgment by the European Court of Justice was made following a case brought in Britain by U.S. company International Stem Cell Corporation (ISCO.PK) over whether it could patent processes covering the use of human egg cells.

The case is significant because three years ago the EU court ruled that stem cell research involving human embryos could not be patented, a decision condemned at the time by some scientists as a "devastating" blow for medical research in Europe.

As a result of that 2011 ruling, Britain's patent office objected to a patent application from the California-based company.

Although work on stem cell therapies is still experimental, researchers believe they have potential to treat a range of diseases from Parkinson's to blindness. But rigid curbs on obtaining patents could hobble their commercialization.

International Stem Cell, however, uses processes based on unfertilized human eggs and the EU court ruled that such eggs should be excluded from the ban on embryo-derived stem cell patents, if it was proven they could not develop into human beings.

"The mere fact that a parthenogenetically-activated human ovum commences a process of development is not sufficient for it to be regarded as a 'human embryo'," the court ruled. Parthenogenesis is the development of unfertilized eggs.

The court said it left it to British judges to determine whether the specific cells used by the U.S. company lacked the inherent capacity of developing into human beings and therefore met these criteria.

Adam Cooke, a partner at law firm DLA Piper, representing International Stem Cell, said the court's decision was "a big step in the right direction". In addition to the patent application in Britain, the company is also seeking patents at the European Patent Office.

Its parthenogenetic stem cells are in pre-clinical development for treating severe diseases of the eye, the nervous system and the liver.

Stem cell research has long been controversial. Critics argue that using embryonic stem cells is wrong because obtaining these cells involves the destruction of embryos which are left over from fertility treatment.

Scientists contend the research is justified, since the embryonic stem cells they use are cell lines derived from original surplus eggs that can be maintained indefinitely. While adult stem cells are also being investigated as potential medicines, they are less flexible than embryonic ones.

"WHERESOEVER YOU GO, GO WITH ALL YOUR HEART." - Confucius

FACT: Female stem cells are better at regeneration than male stem cells.

QUESTION: Is this why women have fewer heart attacks?
ANSWER: Actually, women don't have fewer heart attacks than men.

Heart disease is the leading cause of death for women in the United States, killing 292,188 women in 2009—that’s 1 in every 4 female deaths.¹

Although heart disease is sometimes thought of as a "man's disease," around the same number of women and men die each year of heart disease in the United States. Despite increases in awareness over the past decade, only 54% of women recognize that heart disease is their number 1 killer.²

The fact is, women have heart attacks at about the same rate as men...but their stem cells ARE still better. Male or female, if you have cardiac disease, there is hope!

Heart stem cell treatment info: http://heartstemcells.com/

- Repair Stem Cell Institute

Texas Heart Institute

Female stem cells could be better for heart repair, disease treatment - Nov 16, 2014

Above is a pig heart, which has been stripped of all its cells, leaving only the scaffolding to grow a new heart with human stem cells. This approach may be used in the future to repair heart damage or even generate new hearts for transplantation. Pig hearts are used because they are of a similar size and complexity to human hearts.

“We always knew women were awesome,” said Doris Taylor, director of Regenerative Medicine Research at the Texas Heart Institute. “Now we have the science to back it up.”

...female stem cells, derived from animal muscle tissue, generated more muscle fiber and survived better when repairing injured muscle than male cells... via

Additional research from ScienceDaily - 2007

"BUBBLE BABY" CURE!
Groundbreaking! First ever! Pioneers! New breakthrough!
There's only one problem...

THE OFFENSE:
It gets harder and harder to celebrate the medical advances when the media and medical industry promote those advances as "the world's first" and...they are completely lying with abundant documented proof to the contrary.

THIS WEEKS (BS) HEADLINES:

Doctor discovers cure for 'Bubble Baby' disease
Stem Cell Researcher Pioneers Gene Therapy Cure for ...
and from our friends a CIRM:

"Today, a UCLA research team...announced a stunning breakthrough cure..."

THE PROBLEM:
So what's the problem? Nothing much, just that they are 12 years late!

In 2002, Israeli and Italian Scientists treated and cured two babies with "Bubble Baby" disease, the rare and fatal hereditary condition known as Severe Combined Immunodeficiency, or SCID. The two babies, a two-year-old baby girl named Salsabil from East Jerusalem and an Italian girl, received a correctly functioning gene in place of the faulty gene that causes the disease...both babies have returned to their homes and are leading normal lives. via

THE PROOF:
Notice these headlines and their associated dates.

New gene therapy protocol: First successful treatment for 'bubble babies' - Jerusalem - June 21, 2002 (This actually is the first in the world! - RSCI)
Israeli team saves the life of Arab ‘bubble baby’ - July 1, 2002
First ever bubble girl cured in 2002! - July 3, 2002
International Bubble Boy cure, based on Israeli research - Release date: 3/6/2009

MORE PROOF - THE PATENT: (Yes, they even patented the procedure!)

Israeli Researcher Patents Cure for 'Bubble Boy' Disease - 3/8/2009, 9:37 PM

We at RSCI are particularly bothered by this story because the accomplishments of a great man and brilliant doctor and scientist are going unsung so the "California Institute of Revisionist Medicine" can spout their misinformation and claim an huge and unearned victory.

THE PUNCH LINE:
The doctor who cured the first 'bubble baby' in the world has been not only a friend, but also a member of our scientific board and a premier treatment destination of RSCI since the inception of our organization.

-Repair Stem Cell Institute

---------------------------------

UCLA Stem-Cell Researcher Cures Children With ‘Bubble Baby’ Disease
Posted 2:59 PM, November 18, 2014 - "A UCLA medical researcher was lauded Tuesday for developing a groundbreaking new stem-cell gene-therapy treatment..." via
(Sorry California, not even close! - RSCI)